Edwards, Adam B. http://orcid.org/0000-0002-7503-3232
Mastaglia, Frank L.
Knuckey, Neville W.
Meloni, Bruno P.
Article History
First Online: 1 July 2020
Compliance with Ethical Standards
:
: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
: Neville W. Knuckey and Bruno P. Meloni are named inventors on several patents for the use of CARPs as therapeutic agents. In addition, Neville W. Knuckey, Bruno P. Meloni and Adam B. Edwards are shareholders in Argenica Therapeutics, which is a company developing R18 as a stroke therapeutic. Frank L. Mastaglia has no conflicts of interest that are directly relevant to the content of this article.
: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.